In vivo clearance of 19F MRI imaging nanocarriers is strongly influenced by nanoparticle ultrastructure
Source abstract
Abstract
Perfluorocarbons hold great promise both as imaging agents, particularly for 19F MRI, and in therapy, such as oxygen delivery. 19F MRI is unique in its ability to unambiguously track and quantify a tracer while maintaining anatomic context, and without the use of ionizing radiation. This is particularly well-suited for inflammation imaging and quantitative cell tracking. However, perfluorocarbons, which are best suited for imaging – like perfluoro-15-crown-5 ether (PFCE) - tend to have extremely long biological retention. Here, we showed that the use of a multi-core PLGA nanoparticle entrapping PFCE allows for a 15-fold reduction of half-life in vivo compared to what is reported in literature. This unexpected rapid decrease in 19F signal was observed in liver, spleen and within the infarcted region after myocardial infarction and was confirmed by whole body NMR spectroscopy. We demonstrate that the fast clearance is due to disassembly of the ~200 nm nanoparticle into ~30 nm domains that remain soluble and are cleared quickly. We show here that the nanoparticle ultrastructure has a direct impact on in vivo clearance of its cargo i.e. allowing fast release of PFCE, and therefore also bringing the possibility of multifunctional nanoparticle-based imaging to translational imaging, therapy and diagnostics.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Lanthanide and Transition Metal Complexes · Advanced MRI Techniques and Applications · Electron Spin Resonance Studies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (70)
Show source-provided references
1. Fluorine (19F) MRS and MRI in biomedicine10.1002/nbm.1570 ↗
2. Quantitative magnetic resonance fluorine imaging: today and tomorrow10.1002/wnan.87 ↗
3. 19 F magnetic resonance imaging (MRI): from design of materials to clinical applications10.1021/cr500286d ↗
4. (19)F MRI for quantitative in vivo cell tracking10.1016/j.tibtech.2010.04.002 ↗
5. Biological applications of magnetic nanoparticles10.1039/c2cs15337h ↗
6. Gadolinium loaded nanoparticles in theranostic magnetic resonance imaging10.1016/j.biomaterials.2012.03.084 ↗
7. In vivo imaging platform for tracking immunotherapeutic cells10.1038/nbt1121 ↗
8. Tracking immune cells in vivo using magnetic resonance imaging10.1038/nri3531 ↗
9. Fluorine-19 cellular MRI detection of in vivo dendritic cell migration and subsequent induction of tumor antigen-specific immunotherapeutic response
10. 19F-perfluorocarbon-labeled human peripheral blood mononuclear cells can be detected in vivo using clinical MRI parameters in a therapeutic cell setting10.1038/s41598-017-19031-0 ↗
11. Fluorine-19 MRI for detection and quantification of immune cell therapy for cancer10.1186/s40425-018-0416-9 ↗
12. In vivo monitoring of inflammation after cardiac and cerebral ischemia by fluorine magnetic resonance imaging10.1161/CIRCULATIONAHA.107.737890 ↗
13. In vivo quantification of inflammation in experimental autoimmune encephalomyelitis rats using fluorine-19 magnetic resonance imaging reveals immune cell recruitment outside the nervous system10.1371/journal.pone.0140238 ↗
14. Imaging rheumatoid arthritis in mice using combined near infrared and 19F magnetic resonance modalities10.1038/s41598-019-50043-0 ↗
15. Selective activation of adenosine A2A receptors on immune cells by a CD73-dependent prodrug suppresses joint inflammation in experimental rheumatoid arthritis10.1126/scitranslmed.3003717 ↗
16. Simultaneous assessment of cardiac inflammation and extracellular matrix remodeling after myocardial infarction10.1161/CIRCIMAGING.117.007453 ↗
17. Emerging magnetic resonance imaging techniques for atherosclerosis imaging10.1161/ATVBAHA.118.311756 ↗
18. Flögel · 2016
19. Probing different perfluorocarbons for in vivo inflammation imaging by 19 F MRI: image reconstruction, biological half-lives and sensitivity10.1002/nbm.3059 ↗
20. Oxygen Carriers (“Blood Substitutes”)Raison d'Etre, Chemistry, and Some Physiology Blut ist ein ganz besondrer Saft 110.1021/cr970143c ↗
21. Labeling cells for in vivo tracking using (19)F MRI10.1016/j.biomaterials.2012.08.048 ↗
22. Perfluorocarbon nanoemulsions with fluorescent, colloidal and magnetic properties10.1016/j.biomaterials.2014.03.006 ↗
23. Long-circulating perfluorooctyl bromide nanocapsules for tumor imaging by 19FMRI10.1016/j.biomaterials.2012.04.037 ↗
24. Perfluorooctyl bromide polymeric capsules as dual contrast agents for ultrasonography and magnetic resonance imaging10.1002/adfm.200800454 ↗
25. Fluorine MR imaging of inflammation in atherosclerotic plaque in vivo10.1148/radiol.14141371 ↗
26. Imaging macrophage distribution and density in mammary tumors and lung metastases using fluorine-19 MRI cell tracking10.1002/mrm.27081 ↗
27. Perfluorocarbons: life sciences and biomedical usesDedicated to the memory of Professor Guy Ourisson, a true RENAISSANCE man10.1002/pola.21937 ↗
28. Probing different perfluorocarbons for in vivo inflammation imaging by 19F MRI: image reconstruction, biological half-lives and sensitivity10.1002/nbm.3059 ↗
29. Randomized safety studies of intravenous perflubron emulsion. II. Effects on immune function in healthy volunteers10.1097/00000539-200010000-00009 ↗
30. Clinical studies of a perfluorochemical whole blood substitute (Fluosol-DA) Summary of 186 cases10.1097/00000658-198201001-00010 ↗
31. Lack of complications in long-term survivors after treatment with Fluosol and oxygen as an adjuvant to radiation therapy for high-grade brain tumors10.1016/0360-3016(93)90283-2 ↗
32. Gadolinium deposition in the brain: summary of evidence and recommendations10.1016/S1474-4422(17)30158-8 ↗
33. A multi-modality platform to image stem cell graft survival in the naïve and stroke-damaged mouse brain10.1016/j.biomaterials.2013.11.085 ↗
34. Non-invasive imaging of transplanted human neural stem cells and ECM scaffold remodeling in the stroke-damaged rat brain by 19F- and diffusion-MRI10.1016/j.biomaterials.2011.12.033 ↗
35. Nanoparticle functionalization and its potentials for molecular imaging10.1002/advs.201600279 ↗
36. A comparative assessment of continuous production techniques to generate sub-micron size PLGA particles10.1016/j.ijpharm.2018.08.044 ↗
37. Microfluidics for producing poly (lactic-co-glycolic acid)-based pharmaceutical nanoparticles10.1016/j.addr.2017.12.015 ↗
38. PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect10.1016/j.addr.2010.10.008 ↗
39. Förster resonance energy transfer-based stability assessment of PLGA nanoparticles in vitro and in vivo10.1021/acsabm.8b00754 ↗
40. Microfluidics-assisted size tuning and biological evaluation of PLGA particles10.3390/pharmaceutics11110590 ↗
41. PLGA-encapsulated perfluorocarbon nanoparticles for simultaneous visualization of distinct cell populations by 19 F MRI10.2217/nnm.15.76 ↗
42. Customizing poly(lactic- co -glycolic acid) particles for biomedical applications10.1016/j.actbio.2018.04.006 ↗
43. Customizable, multi-functional fluorocarbon nanoparticles for quantitative in vivo imaging using 19F MRI and optical imaging10.1016/j.biomaterials.2010.05.069 ↗
44. Design of triphasic poly(lactic- co -glycolic acid) nanoparticles containing a perfluorocarbon phase for biomedical applications10.1039/C7RA13062G ↗
45. Clinically-applicable perfluorocarbon-loaded nanoparticles for in vivo photoacoustic, 19 F magnetic resonance and fluorescent imaging10.7150/ntno.26208 ↗
46. In vivo tracking and 1 H/19 F magnetic resonance imaging of biodegradable polyhydroxyalkanoate/polycaprolactone blend scaffolds seeded with labeled cardiac stem cells10.1021/acsami.8b06096 ↗
47. Multicore liquid perfluorocarbon-loaded multimodal nanoparticles for stable ultrasound and 19F MRI applied to in vivo cell tracking
48. Dissociation of 19F and fluorescence signal upon cellular uptake of dual-contrast perfluorocarbon nanoemulsions10.1007/s10334-018-0723-7 ↗
49. Fiji: an open-source platform for biological-image analysis10.1038/nmeth.2019 ↗
50. Montigon · 2015
51. Early assessment of pulmonary inflammation by 19F MRI in vivo10.1161/CIRCIMAGING.109.902312 ↗
52. Noninvasive detection of graft rejection by in vivo (19) F MRI in the early stage10.1111/j.1600-6143.2010.03372.x ↗
53. Visualization of immune cell infiltration in experimental viral myocarditis by (19)F MRI in vivo10.1007/s10334-013-0391-6 ↗
54. Multifunctional MR monitoring of the healing process after myocardial infarction10.1007/s00395-014-0430-0 ↗
55. Noninvasive imaging of early venous thrombosis by 19 F magnetic resonance imaging with targeted perfluorocarbon nanoemulsions10.1161/CIRCULATIONAHA.114.010962 ↗
56. Mechanisms of polymer degradation and erosion10.1016/0142-9612(96)85755-3 ↗
57. Nanoparticles for “two color” 19F magnetic resonance imaging: towards combined imaging of biodistribution and degradation10.1016/j.jcis.2019.12.083 ↗
58. Blood substitutes Artificial oxygen carriers: perfluorocarbon emulsions
59. Discussion and considerations for the excretion mechanism of perfluorochemical emulsion10.3109/10731198809132602 ↗
60. Acute and subacute toxicity of 100% PFOB emulsion10.3109/10731198809132638 ↗
61. New high O2 carrying perfluorochemical emulsions: toxicity, radiosensitivity of GM-CFC and development of metastases in mice10.1016/0360-3016(89)90272-1 ↗
62. A trimodal imaging platform for tracking viable transplanted pancreatic islets in vivo: F-19 MR, fluorescence, and bioluminescence imaging
63. Improved cellular uptake of perfluorocarbon nanoparticles for in vivo murine cardiac 19F MRS/MRI and temporal tracking of progenitor cells
64. Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats10.2217/17435889.3.5.703 ↗
65. Biodistribution, clearance, and long-term fate of clinically relevant nanomaterials10.1002/adma.201704307 ↗
66. In vivo tracking of human neural stem cells with 19F magnetic resonance imaging10.1371/journal.pone.0029040 ↗
67. Imaging of T-cells and their responses during anti-cancer immunotherapy10.7150/thno.37924 ↗
68. In vivo 19F MRI for cell tracking10.3791/50802-v ↗
69. Fluorinated porphyrin-based theranostics for dual imaging and chemo-photodynamic therapy10.1039/D0TB00083C ↗
70. A versatile theranostic nanoemulsion for architecture‐dependent multimodal imaging and dually augmented photodynamic therapy10.1002/adma.201806444 ↗